Covid-19: Sun Pharma begins phase 2 trial of its phytopharmaceutical drug1 min read 05 Jun 2020, 01:31 PM IST
AQCH, being developed for dengue, has shown broad antiviral effect in in-vitro studies and hence is being tested as a potential treatment option for covid-19
NEW DELHI: Sun Pharmaceutical Industries Ltd on Friday said it has commenced phase-II clinical trial of AQCH, a phytopharmaceutical or a plant derived drug, for the treatment of covid-19. AQCH is the first phytopharmaceutical drug approved for clinical trials by the Drugs Controller General of India (DCGI) as a potential treatment therapy for covid-19.
Select your Category